๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
Zoom Pocast with CEO Stephen O'Hara
0:00
-1:18:51

Paid episode

The full episode is only available to paid subscribers of ๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion

Zoom Pocast with CEO Stephen O'Hara

Zoom cast discussing OptiBiotix Health and ProBiotix Health Plc

Elric Langton | 20 July 2022

I am in the process of producing a miniseries around the human biome, or microbiome, the healthcare trends for ingredients in this area, and how both OptiBiotix Health Plc (AIM: OPTI) and ProBiotix Health Plc (AIM: PBX), which was spun out of OptiBiotix earlier this year, in which investors received an in-specie dividend.

Thiโ€ฆ

This post is for paid subscribers

๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
๐Ÿ“ˆ LEMMING INVESTOR RESEARCH by ๐Ÿ“ˆSmall Company Champion
SkinBioTherapeutics Plc CEO, Stuart Ashman discusses the FY report and blows off steam with an empassioned response to the market reaction, as well as addresses obvious lies centred around the company needing cash. Yes, that old chestnut.
Listen on
Substack App
RSS Feed
Appears in episode
๐ŸSmall Company Champion ๐Ÿ“ˆ